Baillie Gifford & Co. Takes Position in Xometry, Inc. (NASDAQ:XMTR)

Baillie Gifford & Co. purchased a new position in Xometry, Inc. (NASDAQ:XMTR - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 710,196 shares of the company's stock, valued at approximately $30,297,000. Baillie Gifford & Co. owned about 1.43% of Xometry at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in XMTR. Raymond James & Associates raised its stake in Xometry by 0.6% during the 3rd quarter. Raymond James & Associates now owns 287,986 shares of the company's stock valued at $5,290,000 after acquiring an additional 1,586 shares in the last quarter. US Bancorp DE raised its stake in Xometry by 57.7% during the 3rd quarter. US Bancorp DE now owns 5,570 shares of the company's stock valued at $102,000 after acquiring an additional 2,037 shares in the last quarter. Allspring Global Investments Holdings LLC raised its stake in Xometry by 1.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 219,075 shares of the company's stock valued at $9,120,000 after acquiring an additional 2,375 shares in the last quarter. State Street Corp raised its stake in Xometry by 0.3% during the 3rd quarter. State Street Corp now owns 887,139 shares of the company's stock valued at $16,297,000 after acquiring an additional 3,027 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in Xometry by 5.7% during the 4th quarter. Rhumbline Advisers now owns 59,367 shares of the company's stock valued at $2,533,000 after acquiring an additional 3,180 shares in the last quarter. Institutional investors own 97.31% of the company's stock.

Xometry Price Performance

Shares of NASDAQ XMTR traded down $2.67 during mid-day trading on Friday, reaching $32.27. The company had a trading volume of 641,892 shares, compared to its average volume of 629,986. Xometry, Inc. has a 1-year low of $11.08 and a 1-year high of $45.33. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. The stock has a market cap of $1.60 billion, a PE ratio of -30.73 and a beta of 0.65. The company has a 50-day moving average price of $37.09 and a two-hundred day moving average price of $27.60.

Insider Activity

In other Xometry news, CFO James Miln sold 5,386 shares of the business's stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $42.33, for a total value of $227,989.38. Following the transaction, the chief financial officer now owns 102,329 shares in the company, valued at $4,331,586.57. The trade was a 5.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Peter Goguen sold 986 shares of the business's stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $40.08, for a total value of $39,518.88. Following the completion of the transaction, the chief operating officer now owns 168,933 shares in the company, valued at $6,770,834.64. This trade represents a 0.58 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,312 shares of company stock worth $517,537. 16.79% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

XMTR has been the topic of several recent analyst reports. Cantor Fitzgerald reaffirmed an "underweight" rating and set a $12.00 target price on shares of Xometry in a research note on Wednesday, November 6th. Craig Hallum boosted their price objective on Xometry from $20.00 to $30.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. Wedbush reissued an "outperform" rating and issued a $48.00 price objective on shares of Xometry in a research note on Friday, December 20th. UBS Group boosted their price objective on Xometry from $20.00 to $22.00 and gave the stock a "neutral" rating in a research note on Wednesday, November 6th. Finally, Citigroup boosted their price objective on Xometry from $25.00 to $33.00 and gave the stock a "buy" rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $33.33.

Xometry Company Profile

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.